Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond

Eitemau Tebyg

• Management of Type 2 Diabetes – Methods for Addition of Prandial to Basal Insulin
  gan: Helena, W Rodbard, et al.
  Cyhoeddwyd: (2014)
• The Emergence of Biosimilar Insulin Preparations—A Cause for Concern?
  gan: Owens, David R., et al.
  Cyhoeddwyd: (2012)
• SAT-LB026 Basal-Prandial Insulin versus Basal-Sliding-Scale Insulin in the Management of Hyperglycemia in Non-Critically Ill Hospitalized Patients
  gan: Malkhasyan, Victoria, et al.
  Cyhoeddwyd: (2019)
• Equivalent Recombinant Human Insulin Preparations and their Place in Therapy
  gan: Sandow, Juergen, et al.
  Cyhoeddwyd: (2015)
• Insulin degludec/insulin aspart in Japanese patients with type 1 diabetes mellitus: Distinct prandial and basal glucose‐lowering effects
  gan: Haahr, Hanne, et al.
  Cyhoeddwyd: (2016)